Cargando…

Effect of cyclin-dependent kinase 7 silencing on cisplatin sensitivity in endometrial carcinoma cells

The aim of the present study was to determine the effect of cyclin-dependent kinase 7 (CDK7) silencing on the sensitivity of the HEC-1-A endometrial carcinoma cell line to cisplatin [cis-dichlorodiammineplatinum (II), or DDP]. Four CDK7 siRNA fragments were designed and synthesized based on the gene...

Descripción completa

Detalles Bibliográficos
Autores principales:	LIU, WEN-XIN, LIU, XIANG-YU, YU, HU, CHEN, YING, HAO, QUAN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270335/ https://www.ncbi.nlm.nih.gov/pubmed/25411854 http://dx.doi.org/10.3892/mmr.2014.2980

Ejemplares similares

Role of Cyclin-Dependent Kinase Inhibitors in Endometrial Cancer
por: Giannone, Gaia, et al.
Publicado: (2019)

The efficacy of the cyclin-dependent kinase 4/6 inhibitor in endometrial cancer
por: Tanaka, Tomohito, et al.
Publicado: (2017)

Silencing cyclin-dependent kinase inhibitor 3 inhibits the migration of breast cancer cell lines
por: Deng, Miao, et al.
Publicado: (2016)

Expression Profile and Molecular Basis of Cyclin-Dependent Kinases Regulatory Subunit 2 in Endometrial Carcinoma Detected by Diversified Methods
por: Gao, Li, et al.
Publicado: (2022)

Effects of the Cyclin-Dependent Kinase 10 (CDK10) on the Tamoxifen Sensitivity of Keloid Samples
por: Liu, Ying, et al.
Publicado: (2012)

[Retracted] Silencing cyclin‑dependent kinase inhibitor 3 inhibits the migration of breast cancer cell lines
por: Deng, Miao, et al.
Publicado: (2023)

Cyclin-dependent kinases
por: Malumbres, Marcos
Publicado: (2014)

Transcriptional Silencing of MCL-1 Through Cyclin-Dependent Kinase Inhibition in Acute Myeloid Leukemia
por: Tibes, Raoul, et al.
Publicado: (2019)

Cyclin-dependent kinase inhibitor dinaciclib potently synergizes with cisplatin in preclinical models of ovarian cancer
por: Chen, Xiu-Xiu, et al.
Publicado: (2015)

Methylation-Mediated Silencing of MicroRNA-211 Decreases the Sensitivity of Melanoma Cells to Cisplatin
por: Li, Ning, et al.
Publicado: (2019)

Adapalene inhibits the activity of cyclin-dependent kinase 2 in colorectal carcinoma
por: SHI, XI-NAN, et al.
Publicado: (2015)

Potent Activity of Composite Cyclin Dependent Kinase Inhibition against Hepatocellular Carcinoma
por: Shao, Yu-Yun, et al.
Publicado: (2019)

Cyclin-dependent kinase 7 inhibitor THZ1 in cancer therapy
por: Li, Bin-Bin, et al.
Publicado: (2019)

The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer
por: Javed, Aadil, et al.
Publicado: (2023)

Functional Differentiation of Cyclins and Cyclin-Dependent Kinases in Giardia lamblia
por: Kim, Juri, et al.
Publicado: (2023)

Clinical implications and molecular mechanisms of Cyclin-dependent kinases 4 for patients with hepatocellular carcinoma
por: Wei, Zhong-liu, et al.
Publicado: (2022)

Sensitivity of human meningioma cells to the cyclin-dependent kinase inhibitor, TG02
por: von Achenbach, Caroline, et al.
Publicado: (2020)

Cyclin-dependent kinases in C. elegans
por: Boxem, Mike
Publicado: (2006)

The Renaissance of Cyclin Dependent Kinase Inhibitors
por: Ettl, Tobias, et al.
Publicado: (2022)

Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma
por: Greenall, S A, et al.
Publicado: (2017)

Cyclin A2 confers cisplatin resistance to endometrial carcinoma cells via up-regulation of an Akt-binding protein, periplakin
por: Suzuki, Akihisa, et al.
Publicado: (2010)

Cyclin-dependent kinase 7 (CDK7) is an emerging prognostic biomarker and therapeutic target in osteosarcoma
por: Ma, Hangzhan, et al.
Publicado: (2021)

LINC00511 influences cellular proliferation through cyclin-dependent kinases in papillary thyroid carcinoma
por: Xiang, Jingjing, et al.
Publicado: (2020)

Ubiquitylation of cyclin C by HACE1 regulates cisplatin‐associated sensitivity in gastric cancer
por: Jiang, Hong‐yue, et al.
Publicado: (2022)

Coupling function of cyclin‐dependent kinase 2 and Septin2 in the promotion of hepatocellular carcinoma
por: Xu, Chenzhou, et al.
Publicado: (2018)

An Integrative Human Pan-Cancer Analysis of Cyclin-Dependent Kinase 1 (CDK1)
por: Liu, Xuanyou, et al.
Publicado: (2022)

Inhibition of cyclin‐dependent kinase 7 down‐regulates yes‐associated protein expression in mesothelioma cells
por: Miao, Jinbai, et al.
Publicado: (2019)

Silencing RIF1 decreases cell growth, migration and increases cisplatin sensitivity of human cervical cancer cells
por: Mei, Ying, et al.
Publicado: (2017)

Suppression of Angiogenesis by Targeting Cyclin-Dependent Kinase 7 in Human Umbilical Vein Endothelial Cells and Renal Cell Carcinoma: An In Vitro and In Vivo Study
por: Shi, Chung-Sheng, et al.
Publicado: (2019)

Prediction of Cyclin-Dependent Kinase Phosphorylation Substrates
por: Chang, Emmanuel J., et al.
Publicado: (2007)

Cyclin-dependent kinase control of motile ciliogenesis
por: Vladar, Eszter K, et al.
Publicado: (2018)

Cyclin-dependent kinases and rare developmental disorders
por: Colas, Pierre
Publicado: (2020)

Therapeutic targeting of transcriptional cyclin-dependent kinases
por: Galbraith, Matthew D., et al.
Publicado: (2018)

Cyclin-dependent kinase inhibitors in malignant hematopoiesis
por: Schirripa, Alessia, et al.
Publicado: (2022)

Cyclin-dependent kinase 19 upregulation correlates with an unfavorable prognosis in hepatocellular carcinoma
por: Cai, Xiaopeng, et al.
Publicado: (2021)

SOX17 increases the cisplatin sensitivity of an endometrial cancer cell line
por: Zhang, Yongli, et al.
Publicado: (2016)

Novel Expression of EGFL7 in Osteosarcoma and Sensitivity to Cisplatin
por: Liu, Qing, et al.
Publicado: (2020)

RNA silencing of integrin-linked kinase increases the sensitivity of the A549 lung cancer cell line to cisplatin and promotes its apoptosis
por: ZHAO, XIAOZHEN, et al.
Publicado: (2015)

Concomitant Presence of p16/Cyclin‐dependent Kinase 4 and Cyclin D/Cyclin‐dependent Kinase 4 omplexes in LNCaP Prostatic Cancer Cell Line
por: Itoh, Noriyuki, et al.
Publicado: (1997)

Silencing of Barkor/ATG14 sensitizes osteosarcoma cells to cisplatin-induced apoptosis
por: ZHAO, ZHIFANG, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_njs5n0dhi816ovj1f7vi3tua0t